The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response
Titel:
The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response
Auteur:
Granadillo, Milaid Alfonso, Alain B. Vallespi, Maribel G. Batte, Aileen Soria, Yordanka Brown, Enma Limonta, Miladys Prieto, Yayrà C. Varas, Laura Torrens, Isis